doi: 10.1161/hc3201.092286
(Circulation. 2001;104:729.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
Upregulation of the Cardiac Monocarboxylate Transporter MCT1 in a Rat Model of Congestive Heart Failure
From the Department of Anatomy, Institute of Basic Medical Sciences (E.J., M.J.T., L.B., T.W.B., O.P.O.), and the Institute for Experimental Medical Research, Ullevaal Hospital (E.J., P.K.L., I.S., O.M.S.), University of Oslo, Oslo, Norway; and the Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, UK (C.H., A.P.H.).
Correspondence to Ole M. Sejersted, Institute for Experimental Medical Research, Ullevaal Hospital, N-0407 Oslo, Norway. E-mail o.m.sejersted{at}ioks.uio.no
Background—— Cardiac metabolism becomes more dependent on carbohydrates in congestive heart failure (CHF), and lactate may be used as an important respiratory substrate. Monocarboxylate transporter 1 (MCT1) promotes cotransport of lactate and protons into and out of heart cells and conceivably flux of lactate between cells, because it is abundantly present in the intercalated disk.
Methods and Results—— Six weeks after induction of myocardial infarction (MI) in Wistar rats, left ventricular end-diastolic pressures were >15 mm Hg, signifying CHF. MCT1 and connexin43 protein levels in CHF were 260% and 20%, respectively, of those in sham-operated animals (Sham), and the corresponding mRNA signals were 181% and not significantly changed, respectively. Confocal laserscan immunohistochemistry and quantitative immunogold cytochemistry showed that MCT1 density was much higher in CHF than in Sham both at the surface membrane and in the intercalated disk. In CHF, a novel intracellular pool of MCT1 appeared to be associated with cisternae, some close to the T tubules. In contrast, connexin43 particles, seen exclusively at gap junctions, were substantially fewer. Maximum lactate uptake was 107±15 mmol · L-1 · min-1 in CHF and 42±6 mmol · L-1 · min-1 in Sham cells (P<0.05). The Km values were between 7 and 9 mmol/L (P=NS).
Conclusions—— In cardiomyocytes from CHF rats, (1) the amount of functional MCT1 in the sarcolemma, including in the intercalated disk, is increased several-fold; (2) a new intracellular pool of MCT1 appears; (3) another disk protein, connexin43, is much reduced; and (4) increased reliance on lactate and other monocarboxylates (eg, pyruvate) could provide tight metabolic control of high-energy phosphates.
Key Words: myocardial infarction • MCT1 • lactate • heart failure • immunohistochemistry
This article has been cited by other articles:
 |
|
 |
|
  W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hashimoto, N. Kambara, R. Nohara, M. Yazawa, and S. Taguchi Expression of MHC-{beta} and MCT1 in cardiac muscle after exercise training in myocardial-infarcted rats J Appl Physiol, September 1, 2004; 97(3): 843 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Butz, G. B. McClelland, and G. A. Brooks MCT1 confirmed in rat striated muscle mitochondria J Appl Physiol, September 1, 2004; 97(3): 1059 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yoshida, H. Hatta, M. Kato, T. Enoki, H. Kato, and A. Bonen Relationship between skeletal muscle MCT1 and accumulated exercise during voluntary wheel running J Appl Physiol, August 1, 2004; 97(2): 527 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ventura-Clapier, A. Garnier, and V. Veksler Energy metabolism in heart failure J. Physiol., February 15, 2004; 555(1): 1 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. van Bilsen, P. J.H Smeets, A. J Gilde, and G. J van der Vusse Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res, February 1, 2004; 61(2): 218 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, M. Tonouchi, D. Miskovic, H. Hatta, and A. Bonen T3 increases lactate transport and the expression of MCT4, but not MCT1, in rat skeletal muscle Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E622 - E628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lloyd, C. Brocks, and J. C. Chatham Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H163 - H172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Evans, D. D. Schwartz, and L. B. Gladden Effect of myocardial volume overload and heart failure on lactate transport into isolated cardiac myocytes J Appl Physiol, March 1, 2003; 94(3): 1169 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ashrafian, E. Johannsson, O. M. Sejersted, P. K. Lunde, I. Sjaastad, M. J. Thomas, L. Bergersen, T. W. Blackstad, O. P. Ottersen, C. Heddle, et al. Cardiac Energetics in Congestive Heart Failure Response Circulation, February 12, 2002; 105 (6): e44 - e45. [Full Text] [PDF]
|
|
|
|
|
|
G. Hasenfuss, L. S. Maier, H.-P. Hermann, C. LUers, M. HUnlich, O. Zeitz, P. M.L. Janssen, and B. Pieske Influence of Pyruvate on Contractile Performance and Ca2+ Cycling in Isolated Failing Human Myocardium Circulation, January 15, 2002; 105(2): 194 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M.J Lamers Unmasking of a novel target for blocking harmful Na+ coupled acid extrusion: electrogenic Na+-HCO3- symport Cardiovasc Res, December 1, 2001; 52(3): 339 - 344. [Full Text] [PDF]
|
|